Efficacy of Application of Myriad Matrix to Split Thickness Skin Graft Sites

NCT06647394 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2025-05-25

No results posted yet for this study

Summary

To determine if application of Myriad Matrix to split thickness skin graft donor sites improves post-operative pain and appearance of the wound.

Conditions

  • Skin Grafts

Interventions

PROCEDURE

Matrix Dressing

extracellular matrix dressing soaked in 4% topical lidocaine to the skin graft donor site

Sponsors & Collaborators

  • University of Alabama at Birmingham

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-31
Primary Completion
2026-12-31
Completion
2028-02-29

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06647394 on ClinicalTrials.gov